Clinical Trials Insight: 700050418

Trial Profile

Clinical Trials Insight: 700050418

Phase of Trial: Phase I

Latest Information Update: 12 Jan 2010

At a glance

  • Drugs KP 106; Lisdexamfetamine
  • Indications Attention-deficit hyperactivity disorder
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 12 Jan 2010 Positive results reported in a KemPharm media release.
    • 12 Jan 2010 Status changed from recruiting to completed as reported in a KemPharm media release.
    • 28 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top